Table 2.
Total n = 128 (100%) | Muscle quantity loss n = 67 (52%) | No muscle quantity loss n = 61 (48%) | P-value | Muscle quality loss n = 83 (65%) | No muscle quality loss n = 45 (35%) | P-value | |
---|---|---|---|---|---|---|---|
Complicated postoperative course | 52 (40.6%) | 25 (37.3%) | 27 (44.3%) | 0.424 | 39 (47%) | 13 (28,9%) | 0.047 |
Cardiopulmonary | 23 (18.0%) | 10 (14.9%) | 13 (21.3%) | 0.347 | 17 (20.5%) | 6 (13.3%) | 0.315 |
Incisional SSI | 8 (6.3%) | 5 (7.5%) | 3 (4.9%) | 0.552 | 6 (7.2%) | 2 (4.4%) | 0.534 |
Intra-abdominal SSI | 10 (7.8%) | 5 (7.5%) | 5 (8.2%) | 0.877 | 8 (9.6%) | 2 (4.4%) | 0.296 |
Infectious, other | 6 (4.7%) | 5 (7.5%) | 1 (1.6%) | 0.120 | 1 (1.2%) | 1 (2.2%) | 0.658 |
Bacteraemia | 2 (1.6%) | 2 (3.0%) | 0 (0.0%) | 0.174 | 6 (7.2%) | 0 (0.0%) | 0.065 |
Bile leak (≥ ISGLS Grade B) | 5 (3.9%) | 1 (1.5%) | 4 (6.6%) | 0.140 | 3 (3.6%) | 2 (4.4%) | 0.817 |
DGE (grade A, B or C) | 5 (3.9%) | 2 (3.0%) | 3 (4.9%) | 0.573 | 4 (4.8%) | 1 (2.2%) | 0.469 |
Thromboembolic event | 3 (2.3%) | 1 (1.5%) | 2 (3.3%) | 0.505 | 2 (2.4%) | 1 (2.2%) | 0.947 |
Bleeding | 1 (0.8%) | 1 (1.5%) | 0 (0.0%) | 0.338 | 1 (1.2%) | 0 (0.0%) | 0.460 |
Single organ failure | 3 (2.3%) | 1 (1.5%) | 2 (3.3%) | 0.505 | 2 (2.4%) | 1 (2.2%) | 0.947 |
Other | 11 (8.6%) | 5 (7.5%) | 6 (9.8%) | 0.632 | 9 (10.8%) | 2 (4.4%) | 0.217 |
Clavien–Dindo ≥ 3 | 18 (14.1%) | 9 (13.4%) | 9 (14.8%) | 0.830 | 13 (15.7%) | 5 (11.1%) | 0.479 |
Length of hospital stay, mean (SD) | 9.7 (5.3) | 9.4 (4.5) | 10.0 (6.2) | 0.522 | 10.3 (4.3) | 8.6 (6.8) | 0.084 |
SSI surgical site infection, ISGLS International Study Group of Liver Surgery, DGE delayed gastric emptying, SD standard deviation, CT computed tomography
The values given are numbers of patients unless indicated otherwise. Bold variables were considered statistically significant (P < 0.05)